Last updated: July 11, 2026

Application No. 18/705,178

Untitled Application

Unknown

Filed

1600

Priority

Oct 28, 2021 — provisional 63/273,111 +1 more

Examiner

LADD, CAROLYN LOUISE

Art Unit

1629

Tech Center

Bristol-Myers Squibb Company

Assignee

Bristol-Myers Squibb Company

OA Round

1 (Non-Final)

This examiner grants 56% of cases after interview

— +47.4% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 78 resolved cases, 2023–2026

Examiner Intelligence

LADD, CAROLYN LOUISE View full profile →

Grants 56% of resolved cases

Career Allowance Rate

44 granted / 78 resolved

-3.6% vs TC avg

Strong +47% interview lift

Without

With

+47.4%

Interview Lift

resolved cases with interview

Typical timeline

3y 6m

Avg Prosecution

33 currently pending

Career history

104

Total Applications

across all art units

Statute-Specific Performance

§103

33.7%

-6.3% vs TC avg

§102

15.4%

-24.6% vs TC avg

§112

22.9%

-17.1% vs TC avg

Black line = Tech Center average estimate • Based on career data from 78 resolved cases

Prosecution Timeline

1600

Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

18/017,416

Patent 12673061

UNIT DOSAGE COMPOSITION OF AKT INHIBITOR

3y 5m to grant Granted Jul 07, 2026

17/604,852

Patent 12662464

DEGRADERS OF CYCLIN-DEPENDENT KINASE 12 (CDK12) AND USES THEREOF

4y 8m to grant Granted Jun 23, 2026

17/920,544

Patent 12655130

5-MEMBERED HETEROARYL CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV

3y 7m to grant Granted Jun 16, 2026

18/017,113

Patent 12636272

METHOD AND COMPOSITION FOR INHIBITING VIRUS INFECTION

3y 4m to grant Granted May 26, 2026

17/629,824

Patent 12622918

FORMULATIONS AND DOSAGES FOR ADMINISTERING A COMPOUND THAT INHIBITS MCL1 PROTEIN

4y 3m to grant Granted May 12, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

56%

Grant Probability

99%

With Interview (+47.4%)

3y 6m

Median Time to Grant

Low

PTA Risk

Based on 78 resolved cases by this examiner. Grant probability derived from career allowance rate.